Vaccine Type: Protein Subunit
This vaccine is approved.
About Trial Phases
There are no trials for this phase.
Caribbean Regulatory System Emergency Use Recommendation
WHO Emergency Use Listing
This vaccine is the same formulation as the Novavax vaccine (NVX-CoV2373)
Total Enrollment: 1,600
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form